Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT06052306 |
| Title | A Study to Learn How Safe the Study Treatment Actinium-225-macropa-pelgifatamab (BAY3546828) is, How it Affects the Body, How it Moves Into, Through and Out of the Body, and About Its Anticancer Activity in Men With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC) |
| Recruitment | Recruiting |
| Gender | male |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Bayer |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | NLD | GBR |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| HUS, Meilahden sairaala | RECRUITING | Helsinki | 00290 | Finland | Details | |
| CRST Clinical Research Services Turku | NOT_YET_RECRUITING | Turku | 20520 | Finland | Details | |
| Universitair Medisch Centrum Groningen | NOT_YET_RECRUITING | Groningen | 9713 GZ | Netherlands | Details | |
| Addenbrookes Hospital | NOT_YET_RECRUITING | Cambridge | Cambridgeshire | CB2 0QQ | United Kingdom | Details |
| Royal Marsden NHS Trust (Surrey) | RECRUITING | Sutton | Surrey | SM2 5PT | United Kingdom | Details |